Navigation Links
Abuse-Deterrent Medication Developer, Pisgah Laboratories, Achieves Top 5 Technologies Ranking
Date:11/27/2012

WASHINGTON, Nov. 27, 2012 /PRNewswire-USNewswire/ -- The not-for-profit Center for Lawful Access and Abuse Deterrence (CLAAD) today announced that it has selected Pisgah Laboratories' abuse-deterrent technology platform as one of its Top 5 Technologies To Reduce Prescription Drug Abuse.

Pisgah Laboratories' lead abuse-deterrent technology product candidate Hydrocodone/APAP, is intended to provide relief to patients in need of treatment, yet lessen the potential for drug abuse.

According to Bill Bristol, the company's founder and CEO, "Employing organic chemistry, Pisgah's technology addresses prescription drug abuse at the core of the demand, a product's active ingredient.  We're grateful for CLAAD's recognition of our innovation."

The Top 5 Technologies competition aims to increase public awareness of the U.S. prescription drug abuse epidemic, and to support private-sector efforts to address the problem.

Michael Barnes, spokesman for CLAAD, stated, "We support Pisgah's efforts to develop novel medications to advance patient care and simultaneously inhibit abuse."  

San Diego-based Millennium Laboratories co-sponsored the Top 5 Technologies contest.  Millennium provides medication monitoring, drug detection and pharmacogenetic testing services.

"We are proud to recognize Pisgah Laboratories for joining Millennium and CLAAD in our efforts to advance patient care and reduce prescription drug abuse," said Howard Appel, President of Millennium Laboratories. 

About the Center for Lawful Access and Abuse Deterrence
The not-for-profit Center for Lawful Access and Abuse Deterrence (CLAAD) is a national coalition of health care providers, law enforcement, community organizations, and businesses working together to reduce prescription drug abuse while optimizing patient care. CLAAD's National Prescription Drug Abuse Prevention Strategy, which has earned the endorsements of 30 non-profit organizations, identifies the adoption of new technologies as an essential component of prescription drug abuse prevention policy.  Visit claad.org, and follow @claad_coalition

About Millennium Laboratories
Millennium Laboratories is the leading research-based, clinical diagnostic company dedicated to improving the lives of people with chronic pain and/or addiction. The company provides healthcare professionals with medication monitoring, drug detection and pharmacogenetic testing services to personalize treatment plans to improve clinical outcomes and patient safety. 

About Pisgah Laboratories, Inc.
Pisgah Laboratories is uniquely positioned to help fill empty product pipelines with a host of abuse-deterrent pain management products which are patent protected and offer performance-enhancing benefits. For licensing or product development opportunities, please contact Todd Stamps at 803-212-8224 for additional information.


'/>"/>
SOURCE CLAAD
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Grant & Eisenhofer Represents Lead Whistleblower in Historic $1.6 Billion Settlement with Abbott Laboratories Over Off-Label Marketing of Antiepileptic Medication Depakote
2. Failure to Take Medicine Linked to Unnecessary Hospital Visits, Especially for Medicare Patients Taking High Blood Pressure or High Cholesterol Medications
3. CVS Caremark Sponsored Research Finds FDA Drug Warnings Can Have Immediate Negative Impact on Medication Adherence, Even if Not Related to Safety
4. Community Pharmacists Take on Medication Non-Adherence to Improve Patient Health
5. MedVantx MedStart™ Solves Problem Highlighted in Study Published in Journal of the American Board of Family Medicine - Expired Medications in Physician Office Sample Closets
6. Omnicell Repeats Best in KLAS Award for OmniRx Automated Medication Dispensing System
7. Talyst Announces New Automated Medication Packager
8. Obesity journal publishes new study on lorcaserin, a weight-loss medication recommended for approval by FDA advisory panel
9. CVS Caremark Research Identifies Positive Link Between Medication Adherence and Employee Productivity
10. China Health Resource Develops Revolutionary Migraine Medication
11. HarborPath Creates a Single Portal for Uninsured Individuals to Access HIV/AIDS Medications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... 27, 2017 On Friday, benchmark ... Composite closed the trading session up 0.19%; the Dow ... 500 was down 0.08%. US markets made broad based ... day in green. Pre-market today, Stock-Callers.com reviews these four ... (NASDAQ: WMGI), Amedica Corporation (NASDAQ: AMDA), MiMedx Group Inc. ...
(Date:3/27/2017)... Calif. , March 27, 2017  Impax Laboratories, ... has appointed Paul M. Bisaro as Impax,s ... the Company,s Board, effective March 27, 2017. Mr. Bisaro ... served as Interim President and Chief Executive Officer since ... of generic and branded pharmaceutical experience, Mr. Bisaro, 56, ...
(Date:3/27/2017)... , March 27, 2017 Arena Pharmaceuticals, Inc. ... on developing novel, small molecule drugs across multiple therapeutic areas, ... Chief Executive Officer, will present a corporate update at the ... 3:40pm ET.  The conference will take place April 4-5, 2017 ... New York , NY.  A live ...
Breaking Medicine Technology:
(Date:3/27/2017)... ... 2017 , ... EpiGentek , a Farmingdale, NY-based biotech ... methylation “gold rush” with their established portfolio of optimized assay kits that measure ... m6A , RNA methylation has received a new burst in interest as ...
(Date:3/27/2017)... ... March 27, 2017 , ... The Anaheim Hills office accelerates ... National Capital has added 10 new sales professionals over the past 6 months and ... 15 additional new hires over the course of 2017. , “This new office ...
(Date:3/27/2017)... ... March 27, 2017 , ... From 1999 to ... responsible for over 33,000 of the 52,404 drug-related deaths in 2015.(2) To combat ... which proposes a tax on prescription opioids to fund drug rehabilitation and prevention ...
(Date:3/25/2017)... ... March 25, 2017 , ... Norland at Swissray is pleased to announce ... large subjects. The ELITE DXA has an active scan window, which is more than ... to fit in the scan area could not undergo an accurate total body bone density ...
(Date:3/24/2017)... , ... March 24, 2017 , ... Digital Scientists, a ... to announce the opening of a Greenville, South Carolina location. The lab ... progress in Greenville. , “We’ve been working with South Carolina clients for years from ...
Breaking Medicine News(10 mins):